“…It was reported that tumor necrosis factor TNF α) antagonists, which are infliximab, etanercept, and adalimumab, improve symptoms in patients with eye, mucocutaneous, and gastrointestinal involvement, as well as neurological disease, and even pulmonary artery aneurysms (Sfikakis PP et al, 2007). Corticosteroids are widely used in the treatment of Behçet disease (Yazici Y et al, 2010).…”